C12N 2501/054
Muramyle peptides
C12N2501/054 (Muramyle peptides) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 3
- Assignees
- 4
- Inventors
- 7
- Latest grant
- 9 Aug 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Pharmaceutical composition comprising stem cells treated with NOD2 agonist or culture thereof for prevention and treatment of immune disorders and inflammatory diseases9 Aug 2016US 9,408,873 B2Kang Stem Biotech Co., Ltd.
- Method of assaying immunization stimulating activity1 Mar 1994US 5,290,681 AMorinaga & Co., Ltd.
- Nod2-dependent pathway of cytoprotection of stem cells19 Oct 2017US 2017/0296621 A1Institut Pasteur
- Nod2-dependent pathway of cytoprotection of stem cells3 Dec 2015US 2015/0343018 A1Institut Pasteur
- "Pharmaceutical Composition Comprising Stem Cells Treated with NOD2 Agonist or Culture Thereof for Prevention and Treatment of Immune Disorders and Inflammatory Diseases"15 Aug 2013US 2013/0209422 A1Kang Stem Holdings Co., Ltd
Most cited
By later US patents